Literature DB >> 23797816

MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Jinglei Miao1, Song Wu, Zhi Peng, Mousumi Tania, Chaoyue Zhang.   

Abstract

MicroRNAs (miRNAs) are small RNA molecules, which can interfere with the expression of several genes and act as gene regulator. miRNAs have been proved as a successful diagnostic and therapeutic tool in several cancers. In this review, the differential expression of miRNAs in osteosarcoma and their possibility to be used as diagnostic and therapeutic tools have been discussed. Osteosarcoma is the most common primary bone tumor that mainly affects children and adolescents. The current treatment of osteosarcoma remains difficult, and osteosarcoma causes many deaths because of its complex pathogenesis and resistance to conventional treatments. Several studies demonstrated that the differential expression patterns of miRNAs are a promising tool for the diagnosis and treatment of osteosarcoma. Although some aspect of the mechanism of action of miRNAs in controlling osteosarcoma has been identified (e.g., targeting the Notch signaling pathway), it is far beyond to the clear understanding of miRNA targets in osteosarcoma. Identification of the specific target of miRNAs may aid molecular targets for drug development and future relief of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23797816     DOI: 10.1007/s13277-013-0940-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

1.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

2.  miRNA-34c regulates Notch signaling during bone development.

Authors:  Yangjin Bae; Tao Yang; Huan-Chang Zeng; Philippe M Campeau; Yuqing Chen; Terry Bertin; Brian C Dawson; Elda Munivez; Jianning Tao; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-04-12       Impact factor: 6.150

3.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Authors:  Hao Zhang; Xiaobing Cai; Yang Wang; Hao Tang; Daki Tong; Fang Ji
Journal:  Oncol Rep       Date:  2010-11       Impact factor: 3.906

Review 4.  Current treatment of osteosarcoma.

Authors:  W S Ferguson; A M Goorin
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

5.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

6.  Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.

Authors:  Riccardo Di Fiore; Daniele Fanale; Rosa Drago-Ferrante; Ferdinando Chiaradonna; Michela Giuliano; Anna De Blasio; Valeria Amodeo; Lidia R Corsini; Viviana Bazan; Giovanni Tesoriere; Renza Vento; Antonio Russo
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

7.  Osteosarcoma of medial cuniform bone.

Authors:  Daniel Admassi
Journal:  Ethiop Med J       Date:  2009-10

8.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

9.  MicroRNA Involvement in Osteosarcoma.

Authors:  Eisuke Kobayashi; Francis J Hornicek; Zhenfeng Duan
Journal:  Sarcoma       Date:  2012-04-03

10.  At-risk populations for osteosarcoma: the syndromes and beyond.

Authors:  George T Calvert; R Lor Randall; Kevin B Jones; Lisa Cannon-Albright; Stephen Lessnick; Joshua D Schiffman
Journal:  Sarcoma       Date:  2012-03-12
View more
  69 in total

Review 1.  Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.

Authors:  Jonathan A R Gordon; Martin A Montecino; Rami I Aqeilan; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

2.  MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.

Authors:  Hong-Min Zhao; Wei Wei; Yu-Hui Sun; Jian-Hua Gao; Qi Wang; Jian-Hua Zheng
Journal:  Tumour Biol       Date:  2015-04-07

3.  MicroRNA-150 upregulation reduces osteosarcoma cell invasion and metastasis by downregulating Ezrin.

Authors:  Ce Zhan; Cheng Li; Hao Zhang; Hao Tang; Fang Ji; Su-Chi Qiao; Wei-Dong Xu; Zhi-Wei Wang
Journal:  Oncol Lett       Date:  2016-08-25       Impact factor: 2.967

4.  MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression.

Authors:  Wenbo He; Lin Feng; Dongliang Xia; Nuan Han
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.

Authors:  Zhi-cai Shi; Xue-rong Chu; Yun-gang Wu; Jin-hui Wu; Chun-wen Lu; Run-xiao Lü; Mu-chen Ding; Ning-fang Mao
Journal:  Tumour Biol       Date:  2015-06-03

6.  MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.

Authors:  Jian-Qiang Xu; Wei-Bin Zhang; Rong Wan; Yao-Qi Yang
Journal:  Tumour Biol       Date:  2014-07-03

7.  Establishment and analysis of osteosarcoma cell sublines with different metastatic characteristics.

Authors:  Zhi Li; Youjun Li; Nan Wang; Lifeng Yang; Wei Zhao; Xiandong Zeng
Journal:  Tumour Biol       Date:  2014-05-27

8.  Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.

Authors:  Deyao Wu; Xiaobing Niu; Huixing Pan; Yunfeng Zhou; Zichun Zhang; Ping Qu; Jian Zhou
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

Review 9.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

10.  Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.

Authors:  Yue Xu; Shuhua Zhao; Manhua Cui; Qiang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.